Hillsdale Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,431
Closed -$299K 649
2024
Q1
$299K Hold
3,431
0.02% 355
2023
Q4
$283K Buy
3,431
+2,070
+152% +$158K 0.02% 343
2023
Q3
$107K Buy
1,361
+710
+109% +$59.4K 0.01% 397
2023
Q2
$57.4K Hold
651
0.01% 404
2023
Q1
$52.5K Hold
651
﹤0.01% 498
2022
Q4
$50.6K Buy
651
+440
+209% +$35.7K ﹤0.01% 486
2022
Q3
$17K Sell
211
-211
-50% -$19K ﹤0.01% 482
2022
Q2
$38K Sell
422
-62
-13% -$6.28K ﹤0.01% 465
2022
Q1
$54K Sell
484
-121
-20% -$12.8K ﹤0.01% 467
2021
Q4
$63K Hold
605
﹤0.01% 475
2021
Q3
$76K Hold
605
0.01% 445
2021
Q2
$75K Buy
+605
New +$76K 0.01% 438
2021
Q1
Sell
-645
Closed -$75K 627
2020
Q4
$75K Buy
645
+320
+98% +$35.2K 0.01% 420
2020
Q3
$34K Sell
325
-285
-47% -$28.6K ﹤0.01% 447
2020
Q2
$56K Sell
610
-90
-13% -$8.63K 0.01% 423
2020
Q1
$63K Buy
700
+80
+13% +$8.51K 0.01% 432
2019
Q4
$71K Buy
620
+40
+7% +$4.39K 0.01% 430
2019
Q3
$63K Hold
580
0.01% 436
2019
Q2
$56K Hold
580
0.01% 439
2019
Q1
$53K Buy
+580
New +$51.9K ﹤0.01% 425

Other funds holding MDT

Hillsdale Investment Management's MDT Position: Q2 2024 in Review

Hillsdale Investment Management sold out of Medtronic (MDT) in Q2 2024, closing a stake of 3,431 shares — an estimated $299K sold.

Hillsdale Investment Management first reported a position in MDT in Q1 2019 and held it in 20 quarters. The position peaked at $299K in Q1 2024. 2,024 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Hillsdale Investment Management reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 3,431 Medtronic shares in Q2 2024, an estimated $299K.
  • Hillsdale Investment Management first reported a position in Medtronic in Q1 2019 and held it in 20 quarters.
  • Hillsdale Investment Management's Medtronic position peaked at $299K in Q1 2024.
  • 2,024 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.